Kolon Life Science Inc. (KOSDAQ:102940)

Kolon Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,567	12,498	7,561	6,371	27,800	15,001
Short-Term Investments	-	-	-	-	110	30
Cash & Short-Term Investments	7,567	12,498	7,561	6,371	27,910	15,031
Cash Growth	-42.95%	65.29%	18.68%	-77.17%	85.69%	-28.13%
Accounts Receivable	36,751	36,699	24,605	29,440	19,649	22,199
Other Receivables	239.42	1,094	1,008	302.04	638.16	398.12
Receivables	36,991	37,794	25,613	29,742	20,287	22,597
Inventory	52,833	46,726	67,777	68,494	45,998	42,790
Prepaid Expenses	3,732	4,127	3,406	4,579	3,743	7,237
Other Current Assets	734.54	909.02	688.31	998.16	82.57	12,908
Total Current Assets	101,858	102,055	105,045	110,184	98,021	100,563
Property, Plant & Equipment	131,750	115,076	123,138	125,960	131,481	141,893
Long-Term Investments	402,751	197,223	77,054	75,240	2,549	3,262
Goodwill	-	-	-	1,217	1,217	1,217
Other Intangible Assets	1,087	554.34	168.28	58.95	99.11	199.79
Long-Term Accounts Receivable	0	-0	0	-0	-0	-0
Long-Term Deferred Charges	6	44.86	164.25	283.64	403.04	522.43
Other Long-Term Assets	4,684	4,610	3,866	1,174	888.54	680.57
Total Assets	642,136	419,563	309,436	314,118	234,658	248,338
Accounts Payable	12,974	11,950	7,442	17,049	13,774	11,808
Accrued Expenses	4,280	4,908	4,355	3,594	3,145	2,721
Short-Term Debt	100,709	105,890	97,262	69,461	59,064	61,751
Current Portion of Long-Term Debt	4,994	9,993	-	4,000	5,333	5,333
Current Portion of Leases	713.36	692.76	428.66	287.62	336.45	348.65
Current Income Taxes Payable	51.72	-	-	376.36	-	-
Current Unearned Revenue	3,201	3,201	3,201	3,201	3,500	3,500
Other Current Liabilities	56,202	69,620	15,653	11,608	10,316	59,689
Total Current Liabilities	183,125	206,255	128,341	109,578	95,469	145,152
Long-Term Debt	14,860	8,699	9,980	-	4,000	9,333
Long-Term Leases	1,090	1,324	191.33	167.18	191.02	262.15
Pension & Post-Retirement Benefits	6,191	6,831	6,439	9,812	10,449	9,730
Long-Term Deferred Tax Liabilities	76,503	33,629	9,874	9,760	-	-
Other Long-Term Liabilities	13,954	13,487	16,938	17,078	25,139	25,903
Total Liabilities	295,724	270,225	171,764	146,395	135,248	190,381
Common Stock	6,212	6,212	5,706	5,706	5,706	5,706
Additional Paid-In Capital	192,801	192,801	167,553	209,114	209,542	167,980
Retained Earnings	-193,671	-228,091	-133,289	-101,537	-106,024	-104,359
Treasury Stock	-	-	-	-	-812.88	-812.88
Comprehensive Income & Other	341,071	178,417	97,702	54,440	-9,001	-10,557
Total Common Equity	346,412	149,338	137,672	167,723	99,410	57,957
Shareholders' Equity	346,412	149,338	137,672	167,723	99,410	57,957
Total Liabilities & Equity	642,136	419,563	309,436	314,118	234,658	248,338
Total Debt	122,366	126,598	107,863	73,916	68,925	77,029
Net Cash (Debt)	-114,799	-114,100	-100,301	-67,545	-41,015	-61,998
Net Cash Per Share	-8323.10	-9553.71	-8788.83	-5344.94	-3597.74	-5438.33
Filing Date Shares Outstanding	12.42	12.42	11.41	11.41	11.4	11.4
Total Common Shares Outstanding	12.42	12.42	11.41	11.41	11.4	11.4
Working Capital	-81,268	-104,200	-23,296	606.75	2,552	-44,589
Book Value Per Share	27884.86	12020.68	12063.41	14696.64	8720.06	5083.88
Tangible Book Value	345,325	148,783	137,504	166,448	98,094	56,541
Tangible Book Value Per Share	27797.38	11976.05	12048.67	14584.86	8604.64	4959.63
Land	16,258	16,281	16,281	17,286	17,008	17,024
Buildings	64,189	81,462	88,069	88,567	88,891	88,874
Machinery	33,746	108,063	104,638	101,589	102,952	90,469
Construction In Progress	15,774	13,857	17,810	16,474	15,952	28,846

Source: S&P Global Market Intelligence. Standard template. Financial Sources.